Allworth Financial LP Oramed Pharmaceuticals Inc. Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Allworth Financial LP holds 300 shares of ORMP stock, worth $696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$696% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORMP
# of Institutions
57Shares Held
7.7MCall Options Held
46.2KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN3.08MShares$7.15 Million5.25% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$4.06 Million1.73% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.96 Million0.04% of portfolio
-
Morgan Jess S & CO Inc366KShares$850,0502.07% of portfolio
-
Rathbones Group PLC Liverpool, X0233KShares$540,6010.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $90.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...